Subscribe to RSS
DOI: 10.1055/s-0043-1768574
B-Cell Lymphoma Intramedullary Tumor: Case Report and Systematic Review
Abstract
Intramedullary tumors represent the major cause of spinal cord injuries, and its symptoms include pain and weakness. Progressive weakness may concomitantly occur in the upper and lower limbs, along with lack of balance, spine tenderness, sensory loss, trophic changes of extremity, hyperreflexia, and clonus. The study protocol was in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. A systematic search of the MEDLINE electronic database was performed to identify the studies reporting the clinical features of children and adults who presented with an intramedullary lymphoma. Twenty-one studies were included, reporting 25 cases. Manuscripts were excluded if the full-text article was not available, original data were not reported (e.g., review articles), or if the main disease was not intramedullary lymphoma. A structured data extraction form was employed to standardize the identification and retrieval of data from manuscripts. To enlighten the discussion, a case is also presented. An 82-year-old woman with Fitzpatrick skin type II, diagnosed and treated for non-Hodgkin's lymphoma 7 years ago, was admitted with mental confusion and memory loss for the past 2 months—evolving with recurring falls from her own height. One day before admission, she displayed Brown-Séquard syndrome. An expansive lesion from C2 to C4 in the cervical spinal cord was found and a hypersignal spinal cord adjacent was described at the bulb medullary transition to the C6–C7 level. A primary spinal cord tumor was considered, as well as a melanoma metastasis, due to the lesion's flame pattern. The patient presented a partial recovery of symptoms and a reduction of the spinal cord edema after being empirically treated with corticosteroids, but the lesion maintained its extent. Subsequently, a large diffuse B-cell lymphoma with nongerminal center was found in open body biopsy, infiltrating neural tissue. The main objective of the present study is to report a surgical case treated for a large diffuse B-cell lymphoma, in addition to presenting the results of a systematic review of primary intramedullary spinal cord lymphoma.
#
Introduction
Spinal tumors are divided into three groups, which are extradural, intradural–extramedullary, and intramedullary spinal cord tumors (IMSCT). They represent approximately 15% of all central nervous system (CNS) tumors. IMSCT is the most uncommon type of spinal tumor. It originates in the spinal cord itself, causing its invasion and destruction of white and gray matter.[1] However, a spinal cord lesion can also be linked to a lymphoma. Primary intramedullary spinal cord lymphoma (PISCL) is one of the rarest spinal diseases, comprising 1% of all CNS lymphomas. It is characterized by a rapid progression in the first year after diagnosis, followed by a slower one after this period.[2] PISCL is an aggressive condition and can emerge directly from CNS, involving the eye, leptomeninges, brain, and spinal cord.[3] Primary CNS lymphoma (PCNSL) has a high possibility of relapse, with poor long-term survival, even though the assigned treatment has advanced. Currently, the treatment of choice in these cases is optimized therapy with high-dose methotrexate-based chemotherapy.[4]
In Brown-Sequard syndrome, the lesion may be completely transverse, initially presenting with asymmetrical spinal cord signs. When an incomplete spinal cord injury (SCI) occurs, some neurologic function will be retained, and one of the syndromes related to that condition is Brown-Séquard syndrome (BSS). The symptoms of BSS, resulting from spinal cord hemisection, present themselves differently in each hemibody. These are weakness and paralysis on one side and painful and thermal sensory loss on the other, with causes ranging from traumatic to nontraumatic, such as tumors, vertebral disk herniation, and tuberculosis.[5]
Individuals of all ages can be affected by spinal metastases. However, these are more frequently reported in patients between 40 and 70 years of age, with the thoracic spine the most affected site and the highest incidence of neurological deficit, followed by the lumbar and cervical spine.[6]
All these concepts are necessary to understanding the following clinical case, in which an 82-year-old woman displays symptoms analogous to the BSS presentation, secondary to an intramedullary lesion. The aim of this investigation is to discuss this rare presentation and enlighten the diagnosis.
#
Methods
The study protocol was in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines.
Population: Adults and children, both genders, across the world.
Exposition: Diagnosed primary intramedullary lymphoma.
Comparison: Age, sex, interval of diagnosis, clinical features, diagnosis, localization,treatment, histological type.
Outcomes: Follow-up and mortality outcomes (alive, deceased).
Search Strategy and Data Sources
A systematic search of the MEDLINE electronic database from February 7 to September 31, 2022 was performed using PubMed's MeSH Advanced Search Builder tool. The search commands can be referred to in Appendix 1.
The search was performed to identify studies reporting clinical features of children and adults who presented with an intramedullary lymphoma. The reference lists of identified studies were examined to identify further reports of interest.
#
Study Selection
Three reviewers independently screened the titles and abstracts of all citations for eligibility and retrieved those that met the inclusion criteria. If insufficient information was available in the abstract to decide on eligibility, the whole article was retrieved for review. Discrepancies were resolved by consensus and utilization of a fourth reviewer when necessary. Manuscripts reporting information on children and adults, both genders, were included when an intramedullary lymphoma was present and the article dated from the last 5 years. Manuscripts were excluded if the full-text article was not available, original data were not reported (e.g., review articles), or if the main disease was not intramedullary lymphoma.
#
Data Extraction
A structured data extraction form was employed to standardize the identification and retrieval of data from manuscripts. Data were organized into a standardized table, where each reviewer extracted the following data from the studies: age, sex, interval of symptom onset, clinical presentation, localization, treatment, histological type, follow-up, and outcome. Where manuscripts did not report the information we were evaluating, we displayed the information as not available.
#
#
Results
For the systematic literature review, of the 963 articles that were found, we selected those within 5 years of publication date, excluding those that did not contain articles reporting primary data (e.g., isolated reviews, meta-analyses, or national database projects) and that were not written in English. In all, 148 articles were screened by the reviewers and articles that did not address lymphoma or were not case reports were excluded (102 articles). Then, 46 articles were screened for primary data and full-text information, including 21 studies to the review ([Fig. 1]).
The 21 selected studies[7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] that met the eligibility criteria are described in [Table 1], reporting a total of 25 cases (20 male and 5 female patients), in the age range of 15 to 79 years (average: 52.72 years). Only 10 cases reported follow-up as 4 patients were lost to follow-up and 11 studies did not report it. The average follow-up was 1.73 years (range: 2 weeks–6 years). Three patients were deceased at the time of report, 7 did not report the information, and 15 patients were alive (6 free of infection, 1 in remission, 1 with remaining disease, and 7 unknown). In terms of location, 4 lesions were located above the cervical region, 5 cervical, 10 thoracic, 7 lumbar, and 1 cauda equina lesions (discriminated in the table), with individual clinical presentations. The time interval from symptoms onset to diagnosis was clearly informed by 22 patients, ranging from 4 days to 1 year (average: 3.6 months). Diagnosis were diffuse large B-cell lymphoma on 10 cases, CNS lymphoma (2 cases—1 spinal), T-lymphoblastic lymphoma (3 cases—1 with cauda equina involvement), large B-cell lymphoma (2 cases), marginal zone lymphoma (1 case), follicular grade I to II lymphoma (1 case), non-Hodgkin's lymphoma (3 cases—2 primary B cell), anaplastic large cell lymphoma (1 case), primary peripheral gamma delta T-cell lymphoma (1 case), and 1 case of B-lymphoblastic lymphoma.
Performed treatment included surgical resection, partial biopsy, chemotherapy, radiotherapy, biological therapy, and corticosteroids. Tumor resection was done in 13 patients, decompressive laminectomies was done in 9 patients, chemotherapy (CT) in 18 patients, corticosteroids in 6 patients, radiotherapy in 4 patients, and biological drugs in 2 patients. The following symptoms appeared recurrently in the case series and may help suspicion for lymphoma if present: constitutional symptoms, back pain, and lower motor neuron involvement.
#
Case Description
An 82-year-old old woman, with Fitzpatrick type II skin, diagnosed and treated for non-Hodgkin's lymphoma 7 years ago, was admitted at the hospital with mental confusion and memory loss for the past 2 months, evolving with recurring falls from height in the last month. A day before hospital admission, her condition aggravated, now exhibiting loss of strength and hemiparesis in the right side of the body, associated with superficial hemiparesthesia in the left side, a clinical condition compatible with BSS, characterized by a spinal cord hemisection, which was confirmed by imaging tests. No other neurological findings were noted.
Computed tomography (CT) scan and magnetic resonance imaging (MRI) showed an expansive lesion from C2 to C4 in the cervical spinal cord ([Fig. 2]). Its dimension was 4.8 × 0.8 × 0.7 cm, homogenous impregnation with gadolinium. There was also a hyperintensity in the spinal cord, from the bulb medullary transition to the C6–C7 level ([Fig. 2]), possibly corresponding with spinal cord edema. After being evaluated by the hemathology, oncology, neurology, and neurosurgery teams, it was not possible to confirm nor reject recidivated lymphoma, for a primary spinal cord tumor (ependymoma, astrocytoma, hemangioblastoma) was possible, as well as a melanoma metastasis, due to the lesion's flame pattern.
The patient presented a partial recovery of symptoms and a reduction of the spinal cord edema after being empirically treated with corticosteroids, but the lesion maintained its extent ([Fig. 3]). A frozen section body biopsy was performed, and the surgical material was sent to anatomopathological and immunohistochemical study ([Table 2]).
A large diffuse B-cell lymphoma with nongerminal center infiltrating neural tissue was found in C2. Therefore, the primary hypothesis was confirmed: lymphoma.
The neurosurgical team performed an excision of the intramedullary cervical lesion ([Fig. 4]), through a lateral intermediate sulcus approach. The patient was neuromonitored intraoperatively and afterward motor rehabilitation was initiated ([Fig. 5]). A discreet improvement of muscle strength on the right hemibody was perceived. Vital signs were stable, besides a few hypertension episodes. The next step was urgent radiotherapy, followed by chemotherapy.
Unfortunately, the patient developed sepsis during chemotherapy 2 weeks after surgical resection and succumbed to the disease.
#
Discussion
Spine tumors can be branched between extradural, intradural extramedullary, and intradural intramedullary, the latter being (IMSCTs) rare neoplasms that can be subdivided into gliomas (ependymomas and astrocytomas) and hemangioblastomas, all of which may be responsible for neurological dysfunction and deterioration.[28] The pathophysiology of these lesions varies: ependymomas are encapsulated tumors, mostly benign; spinal astrocytomas are less aggressive than when developed in the brain, but nerve fiber stretching can cause pain and neurologic defects; hemangioblastomas are highly vascular tumors and can cause mass effect due to capillary hyperpermeability.[29] Also, metastatic intramedullary tumors can occur, usually arising from primary neoplasms such as of the lung and breast.[28] Intramedullary spinal cord metastasis (ISCM) can also be secondary to malignant melanoma, since it can present with paraparesis, quadriparesis, and urinary and/or fecal incontinence, but it is an extremely difficult diagnosis of exclusion.[30]
The primary malignant melanoma is also an intramedullary tumor that can occur in the spinal cord, but it is still little described. It accounts for 1% of all cases of melanoma, indicating the lesion is extremely unique, with the diagnosis requiring histopathological confirmation and excluding metastatic spread from other areas.[30] This diagnosis was considered especially because of the patient's Fitzpatrick type II classification.
Additionally, the patient also had a medical history of a non-Hodgkin's lymphoma from 7 years ago, which hinted to a possible recidivistic lymphoma. Intramedullary lesions can therefore be subdivided into glial tumors, nonglial tumors such as lymphomas and benign lesions, exemplified by epidermoid cysts, lipomas,[28] and, rarely, abscesses.[31]
Lymphomas develop from progressive mutations in the deoxyribonucleic acid (DNA), namely, amplification, deletion, or chromosomal translocations. Non-Hodgkin's lymphomas arise from mature B lymphocytes and may have small portions of T lymphocytes or natural killer cells. Some subtypes may also be associated with infections, such as Epstein–Barr virus, Helicobacter pylori, and hepatitis C virus.[32] Primary central nervous system lymphoma (PCNSL) is an extranodal non-Hodgkin's lymphoma whose known causes can commonly be human immunodeficiency virus (HIV), chronic immunosuppression, and organ transplantation. Studies show that the human T-lymphotropic virus type 1 (HTLV-1) virus can also be associated with the appearance of T-cell lymphomas of the spinal cord. According to Urasaki et al, the virus probably migrates from blood to the parenchyma of the CNS, but does not proliferate. Thus, parainfectious myelitis is believed to occur.[33] However, this disease can develop in immunocompetent patients, as already seen in association with rheumatoid arthritis and systemic lupus erythematosus.[34] These relations could not be found in the patient's history.
The most conclusive sign of intramedullary lesion was the presentation of BSS, which is little described in the literature as a PCNSL manifestation. BSS is a result of hemisection of the spinal cord and manifests with weakness or paralysis and ipsilateral proprioceptive deficits and loss of pain and temperature sensation on the contralateral side of the lesion, indicating a diverse severity.[5] Partial hemisection is more evident and includes nerve tracts in the injured area. Therefore, the sensory sensations affected depend on the site of the lesion ([Table 3]).
Source: Shams and Arain.[5]
The most common intramedullary location is the cervical cord, as seen in our case, followed by the thoracic, then the lumbar cord.[35] It is common to observe a delay on its diagnosis, due to its rarity, similarity to other causes of myelopathy, and the difficulties in obtaining viable histological samples and pathologic diagnosis.[36] Intramedullary spinal cord lymphoma is very rare. It is seen in less than 1% of primary CNS lymphomas.[37]
Longitudinally extensive transverse myelopathy (LETM) is common and is usually inflammatory, demyelinating, related to connective tissue disease, due to sarcoidosis or paraneoplastic causes,[38] but uncommon on lymphomas. The presentation of LETM may be associated with brain lesions, and other differentials such as neuromyelitis optica (NMO) spectrum disorders are considered, leading to delay in diagnosis and may be fatal if not suspected or detected. Two case series of LETM[39] showed that none of the patients evaluated had lymphoma as diagnosis although our patient and one other reported case presented it.[40]
Even though spinal cord expansion is usually present, some patients may have minimal enlargement.[41] Lesions are generally poorly defined, syringomyelia is rare, hemorrhagic component usually does not appear as a component,[42] and cysts are not usually present.[41] Involvement of the brain is reported, within the brainstem, cerebellum, deep gray matter, or cerebral cortex.[43] Peripheral nerve involvement has been described as well.[44]
Reported signal characteristics include T1: isointense to the spinal cord/T2: hyperintense (contrasts with the characteristic low T2 signal intensity that is seen in intracranial lesions)/T1 C+ (Gd): usually solid and homogeneous enhancement.[45]
The patient evolved with loss of strength and hemiparesis on the right side of the body and superficial hemiparesthesia on the left side, thus suggesting BSS, which was confirmed by imaging tests.
#
Conclusion
Intramedullary lesions can be related to several pathologies, such as tumors and lymphomas. Even if the etiology is different, most of the time the clinical presentation is similar. Occurrence of BSS is commonly concurrent to the intramedullary lesions and is valuable evidence of a spinal cord hemisection. Therefore, it is difficult to differentiate the two conditions. In this case, the patient's medical history played a major role in the diagnosis, but the etiology and treatment of the disease could be elucidated only after a biopsy. Thus, it is important to stress the value of surgical procedures to conclude neurological diagnosis.
#
(“lymphoma”[MeSH Terms] OR “lymphoma”[All Fields] OR “lymphomas”[All Fields] OR “lymphoma s”[All Fields] OR (“composite lymphoma”[MeSH Terms] OR (“composite”[All Fields] AND “lymphoma”[All Fields]) OR “composite lymphoma”[All Fields]) OR (“hodgkin disease”[MeSH Terms] OR (“hodgkin”[All Fields] AND “disease”[All Fields]) OR “hodgkin disease”[All Fields]) OR (“lymphoma, non hodgkin”[MeSH Terms] OR (“lymphoma”[All Fields] AND “non hodgkin”[All Fields]) OR “non-hodgkin lymphoma”[All Fields] OR (“lymphoma”[All Fields] AND “non”[All Fields] AND “hodgkin”[All Fields]) OR “lymphoma non hodgkin”[All Fields]) OR (“lymphoma, b cell”[MeSH Terms] OR (“lymphoma”[All Fields] AND “b cell”[All Fields]) OR “b-cell lymphoma”[All Fields] OR “lymphoma b cell”[All Fields]) OR (“lymphoma, follicular”[MeSH Terms] OR (“lymphoma”[All Fields] AND “follicular”[All Fields]) OR “follicular lymphoma”[All Fields] OR (“lymphoma”[All Fields] AND “follicular”[All Fields]) OR “lymphoma follicular”[All Fields]) OR (“lymphoma, large cell, immunoblastic”[MeSH Terms] OR (“lymphoma”[All Fields] AND “large cell”[All Fields] AND “immunoblastic”[All Fields]) OR “immunoblastic large-cell lymphoma”[All Fields] OR (“lymphoma”[All Fields] AND “large”[All Fields] AND “cell”[All Fields] AND “immunoblastic”[All Fields]) OR “lymphoma large cell immunoblastic”[All Fields]) OR (“lymphoma, mantle cell”[MeSH Terms] OR (“lymphoma”[All Fields] AND “mantle cell”[All Fields]) OR “mantle-cell lymphoma”[All Fields] OR (“lymphoma”[All Fields] AND “mantle”[All Fields] AND “cell”[All Fields]) OR “lymphoma mantle cell”[All Fields]) OR (“lymphoma, t cell”[MeSH Terms] OR (“lymphoma”[All Fields] AND “t cell”[All Fields]) OR “t-cell lymphoma”[All Fields] OR “lymphoma t cell”[All Fields]) OR (“lymphoma”[MeSH Terms] OR “lymphoma”[All Fields] OR “lymphomas”[All Fields] OR “lymphoma s”[All Fields]) OR (“lymphoma”[MeSH Terms] OR “lymphoma”[All Fields] OR (“lymphoma”[All Fields] AND “malignant”[All Fields]) OR “lymphoma malignant”[All Fields]) OR (“lymphoma”[MeSH Terms] OR “lymphoma”[All Fields] OR (“lymphomas”[All Fields] AND “malignant”[All Fields]) OR “lymphomas malignant”[All Fields]) OR (“lymphoma”[MeSH Terms] OR “lymphoma”[All Fields] OR (“malignant”[All Fields] AND “lymphoma”[All Fields]) OR “malignant lymphoma”[All Fields]) OR (“lymphoma”[MeSH Terms] OR “lymphoma”[All Fields] OR (“malignant”[All Fields] AND “lymphomas”[All Fields]) OR “malignant lymphomas”[All Fields])) AND (“spinal cord neoplasms”[MeSH Terms] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields]) OR “spinal cord neoplasms”[All Fields] OR (“spinal cord neoplasms”[MeSH Terms] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields]) OR “spinal cord neoplasms”[All Fields] OR (“tumors”[All Fields] AND “spinal”[All Fields] AND “cord”[All Fields]) OR “tumors spinal cord”[All Fields]) OR (“spinal cord tumour”[All Fields] OR “spinal cord neoplasms”[MeSH Terms] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields]) OR “spinal cord neoplasms”[All Fields] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “tumor”[All Fields]) OR “spinal cord tumor”[All Fields]) OR (“spinal cord tumours”[All Fields] OR “spinal cord neoplasms”[MeSH Terms] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields]) OR “spinal cord neoplasms”[All Fields] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “tumors”[All Fields]) OR “spinal cord tumors”[All Fields]) OR (“spinal cord neoplasms”[MeSH Terms] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields]) OR “spinal cord neoplasms”[All Fields] OR (“tumor”[All Fields] AND “spinal”[All Fields] AND “cord”[All Fields]) OR “tumor spinal cord”[All Fields]) OR (“spinal cord neoplasms”[MeSH Terms] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields]) OR “spinal cord neoplasms”[All Fields] OR (“neoplasms”[All Fields] AND “spinal”[All Fields] AND “cord”[All Fields]) OR “neoplasms spinal cord”[All Fields]) OR (“spinal cord neoplasms”[MeSH Terms] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields]) OR “spinal cord neoplasms”[All Fields] OR (“neoplasm”[All Fields] AND “spinal”[All Fields] AND “cord”[All Fields])) OR (“spinal cord neoplasms”[MeSH Terms] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields]) OR “spinal cord neoplasms”[All Fields] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “neoplasm”[All Fields]) OR “spinal cord neoplasm”[All Fields]) OR (“spinal cord neoplasms”[MeSH Terms] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields]) OR “spinal cord neoplasms”[All Fields] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields] AND “malignant”[All Fields])) OR (“spinal cord neoplasms”[MeSH Terms] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields]) OR “spinal cord neoplasms”[All Fields] OR (“intramedullary”[All Fields] AND “spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields] AND “primary”[All Fields])) OR (“spinal cord neoplasms”[MeSH Terms] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields]) OR “spinal cord neoplasms”[All Fields] OR (“primary”[All Fields] AND “intramedullary”[All Fields] AND “spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields]) OR “primary intramedullary spinal cord neoplasms”[All Fields]) OR (“spinal cord neoplasms”[MeSH Terms] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields]) OR “spinal cord neoplasms”[All Fields] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields] AND “primary”[All Fields] AND “intramedullary”[All Fields])) OR (“spinal cord neoplasms”[MeSH Terms] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields]) OR “spinal cord neoplasms”[All Fields] OR (“primary”[All Fields] AND “spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields] AND “intramedullary”[All Fields]) OR “primary spinal cord neoplasms intramedullary”[All Fields]) OR (“spinal cord neoplasms”[MeSH Terms] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields]) OR “spinal cord neoplasms”[All Fields] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields] AND “benign”[All Fields])) OR (“spinal cord neoplasms”[MeSH Terms] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields]) OR “spinal cord neoplasms”[All Fields] OR (“intradural”[All Fields] AND “extramedullary”[All Fields] AND “spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields]) OR “intradural extramedullary spinal cord neoplasms”[All Fields]) OR (“spinal cord neoplasms”[MeSH Terms] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields]) OR “spinal cord neoplasms”[All Fields] OR (“intradural”[All Fields] AND “extramedullary”[All Fields] AND “spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields]) OR “intradural extramedullary spinal cord neoplasms”[All Fields]) OR (“spinal cord neoplasms”[MeSH Terms] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields]) OR “spinal cord neoplasms”[All Fields] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields] AND “intradural”[All Fields] AND “extramedullary”[All Fields])) OR (“spinal cord neoplasms”[MeSH Terms] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields]) OR “spinal cord neoplasms”[All Fields] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields] AND “intradural”[All Fields] AND “extramedullary”[All Fields])) OR (“spinal cord neoplasms”[MeSH Terms] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields]) OR “spinal cord neoplasms”[All Fields] OR (“intramedullary”[All Fields] AND “spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields]) OR “intramedullary spinal cord neoplasms”[All Fields]) OR (“spinal cord neoplasms”[MeSH Terms] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields]) OR “spinal cord neoplasms”[All Fields] OR (“spinal”[All Fields] AND “cord”[All Fields] AND “neoplasms”[All Fields] AND “intramedullary”[All Fields]) OR “spinal cord neoplasms intramedullary”[All Fields])).
#
Conflict of Interest
None declared.
-
References
- 1 Das JM, Hoang S, Mesfin FB. Intramedullary spinal cord tumors. StatPearls; 2022. Accessed August 3, 2022 at: https://www.ncbi.nlm.nih.gov/books/NBK442031/
- 2 Yang W, Garzon-Muvdi T, Braileanu M. et al. Primary intramedullary spinal cord lymphoma: a population-based study. Neuro-oncol 2017; 19 (03) 414-421
- 3 Lv C, Wang J, Zhou M, Xu JY, Chen B, Wan Y. Primary central nervous system lymphoma in the United States, 1975-2017. Ther Adv Hematol 2022; 13: 2040620 7211066166
- 4 Löw S, Han CH, Batchelor TT. Primary central nervous system lymphoma. Ther Adv Neurol Disord 2018; 11: 1756286 418793562
- 5 Shams S, Arain A. Brown Sequard Syndrome. StatPearls; 2022. Accessed August 3, 2022 at: https://www.ncbi.nlm.nih.gov/books/NBK538135/
- 6 Aycan A, Celik S, Kuyumcu F. et al. Spinal metastasis of unknown primary accompanied by neurologic deficit or vertebral instability. World Neurosurg 2018; 109: e33-e42
- 7 Chen W, Hika B, Smith CJ, Parrett TJ, Mesfin FB. A conservative approach to the treatment of a rare case of cervical spine double expressor diffuse large B-cell lymphoma: a case report. Cureus 2022; 14 (01) e21208
- 8 Iriyama C, Murate K, Iba S. et al. Detection of circulating tumor DNA in cerebrospinal fluid prior to diagnosis of spinal cord lymphoma by flow cytometric and cytologic analyses. Ann Hematol 2022; 101 (05) 1157-1159
- 9 Erdem MB, Kale A, Yaman ME, Emmez H. A rare entity in the lumbar epidural region: T-cell lymphoblastic lymphoma. Int J Spine Surg 2021; 14 (s4): S52-S56
- 10 De Vries J, Oterdoom MD, Den Dunnen WF. et al. Primary cauda equina T-cell lymphoblastic lymphoma. World Neurosurg 2020; 142: 227-232
- 11 Natteru PA, Shekhar S, Nair LR, Uschmann H. Primary central nervous system lymphoma mimicking longitudinally extensive transverse myelitis. Neurohospitalist 2021; 11 (02) 170-174
- 12 Wang D, Su M, Xiao J. A rare case of primary ventricular lymphoma presented on FDG PET/CT. Clin Nucl Med 2020; 45 (02) 156-158
- 13 Singh SS, Mittal BR, Kumar R, Singh H, Balaini N, Goyal M. Primary central nervous system lymphoma with diffuse neurolymphomatosis involving multiple cranial and spinal nerve roots. Clin Nucl Med 2020; 45 (06) e285-e287
- 14 Fakhouri F, Shoumal N, Obeid B, Alkhoder A. Primary diffuse large B-cell non-Hodgkin's lymphoma of the thoracic spine presented initially as an epigastric pain. Asian J Neurosurg 2020; 15 (01) 162-164
- 15 Pandey S, Gokden M, Kazemi NJ, Post GR. Hematolymphoid malignancies presenting with spinal epidural mass and spinal cord compression: a case series with rare entities. Ann Clin Lab Sci 2019; 49 (06) 818-828
- 16 Beume LA, Wolf K, Urbach H. et al. Primary intraspinal non-Hodgkin's lymphoma: case report and review of literature. J Clin Neurosci 2019; 61: 262-264
- 17 Yim J, Song SG, Kim S. et al. Primary peripheral gamma delta T-cell lymphoma of the central nervous system: Report of a case involving the intramedullary spinal cord and presenting with myelopathy. J Pathol Transl Med 2019; 53 (01) 57-61
- 18 Feng L, Chen D, Zhou H. et al. Spinal primary central nervous system lymphoma: case report and literature review. J Clin Neurosci 2018; 50: 16-19
- 19 Arslan H, Yavuz A, Aycan A. Primary spinal lymphoma masquerading as meningioma: preoperative and postoperative magnetic resonance imaging findings. World Neurosurg 2018; 118: 86-87
- 20 Li X, Qi S, Jiao Y, Gao J, Du H. A case report of primary central nervous system lymphoma with intestinal obstruction as the initial symptom. Medicine (Baltimore) 2018; 97 (10) e0080
- 21 Suzuki K, Yasuda T, Hiraiwa T, Kanamori M, Kimura T, Kawaguchi Y. Primary cauda equina lymphoma diagnosed by nerve biopsy: a case report and literature review. Oncol Lett 2018; 16 (01) 623-631
- 22 Patel M, Wu OC, Kasliwal MK. Wrap-around appearance: underrecognized radiologic feature of spinal lymphoma. World Neurosurg 2018; 115: 157-158
- 23 Fastré S, London F, Lelotte J, Camboni A, Jeanjean A. Primary central nervous system lymphoma of T-cell origin: an unusual cause of spinal cord disease. Acta Neurol Belg 2017; 117 (03) 765-767
- 24 Geevarghese R, Marcus R, Aizpurua M, Al-Sarraj S, Ashkan K. Non-Hodgkin lymphoma of the cauda equina: a rare entity. Br J Neurosurg 2017; 31 (06) 734-735
- 25 Alaya Z, Achour B. Primary spinal marginal zone lymphoma: an unusual cause of spinal cord compression. Pan Afr Med J 2017; 27: 171
- 26 Chida K, Sugawara A, Koji T. et al. Primary intramedullary malignant lymphoma in the cervical cord with a presyrinx state. Cureus 2017; 9 (12) e2006
- 27 Córdoba-Mosqueda ME, Guerra-Mora JR, Sánchez-Silva MC, Vicuña-González RM, Torre AI. Primary spinal epidural lymphoma as a cause of spontaneous spinal anterior syndrome: a case report and literature review. J Neurol Surg Rep 2017; 78 (01) e1-e4
- 28 Samartzis D, Gillis CC, Shih P, O'Toole JE, Fessler RG. Intramedullary spinal cord tumors: part i-epidemiology, pathophysiology, and diagnosis. Global Spine J 2015; 5 (05) 425-435
- 29 Ogden AT, Francavilla TL. Intramedullary Spinal Cord Tumors. Medscape; 2020. Accessed August 3, 2022 at: https://emedicine.medscape.com/article/251133
- 30 Tuz Zahra F, Ajmal Z, Qian J, Wrzesinski S. Primary intramedullary spinal melanoma: a rare disease of the spinal cord. Cureus 2021; 13 (07) e1619
- 31 Raffa PEAZ, Vencio RCC, Ponce ACC. et al. Spinal intramedullary abscess due to Candida albicans in an immunocompetent patient: a rare case report. Surg Neurol Int 2021; 12: 275
- 32 Bowzyk Al-Naeeb A, Ajithkumar T, Behan S, Hodson DJ. Non-Hodgkin lymphoma. BMJ 2018; 362: k3204
- 33 Urasaki E, Yamada H, Tokimura T, Yokota A. T-cell type primary spinal intramedullary lymphoma associated with human T-cell lymphotropic virus type I after a renal transplant: case report. Neurosurgery 1996; 38 (05) 1036-1039
- 34 Mullangi S, Lekkala MR. CNS Lymphoma. StatPearls; 2021. Accessed August 3, 2022 at: https://www.ncbi.nlm.nih.gov/books/NBK563302/
- 35 Dähnert W. Radiology Review Manual. Nucl Med Commun 2011; 32 (10) 195-196
- 36 Flanagan EP, O'Neill BP, Porter AB, Lanzino G, Haberman TM, Keegan BM. Primary intramedullary spinal cord lymphoma. Neurology 2011; 77 (08) 784-791
- 37 Hochberg FH, Miller DC. Primary central nervous system lymphoma. J Neurosurg 1988; 68 (06) 835-853
- 38 Kitley JL, Leite MI, George JS, Palace JA. The differential diagnosis of longitudinally extensive transverse myelitis. Mult Scler 2012; 18 (03) 271-285
- 39 Cobo-Calvo Á, Alentorn A, Mañé Martínez MA. et al. Etiologic spectrum and prognosis of longitudinally extensive transverse myelopathies. Eur Neurol 2014; 72 (1-2): 86-94
- 40 Elavarasi A, Dash D, Warrier AR. et al. Spinal cord involvement in primary CNS lymphoma. J Clin Neurosci 2018; 47: 145-148
- 41 Fitzsimmons A, Upchurch K, Batchelor T. Clinical features and diagnosis of primary central nervous system lymphoma. Hematol Oncol Clin North Am 2005; 19 (04) 689-703 , vii
- 42 Haque S, Law M, Abrey LE, Young RJ. Imaging of lymphoma of the central nervous system, spine, and orbit. Radiol Clin North Am 2008; 46 (02) 339-361 , ix
- 43 Bekar A, Cordan T, Evrensel T, Tolunay S. A case of primary spinal intramedullary lymphoma. Surg Neurol 2001; 55 (05) 261-264
- 44 Schwarz S, Zoubaa S, Knauth M, Sommer C, Storch-Hagenlocher B. Intravascular lymphomatosis presenting with a conus medullaris syndrome mimicking disseminated encephalomyelitis. Neuro-oncol 2002; 4 (03) 187-191
- 45 Iqbal S, Wein S. Lymphoma of the spinal cord. Radiopaedia.Org.; 2012. Accessed March 17, 2023 at: https://doi.org/10.53347/rid-19279
Address for correspondence
Publication History
Article published online:
06 June 2023
© 2023. Asian Congress of Neurological Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Das JM, Hoang S, Mesfin FB. Intramedullary spinal cord tumors. StatPearls; 2022. Accessed August 3, 2022 at: https://www.ncbi.nlm.nih.gov/books/NBK442031/
- 2 Yang W, Garzon-Muvdi T, Braileanu M. et al. Primary intramedullary spinal cord lymphoma: a population-based study. Neuro-oncol 2017; 19 (03) 414-421
- 3 Lv C, Wang J, Zhou M, Xu JY, Chen B, Wan Y. Primary central nervous system lymphoma in the United States, 1975-2017. Ther Adv Hematol 2022; 13: 2040620 7211066166
- 4 Löw S, Han CH, Batchelor TT. Primary central nervous system lymphoma. Ther Adv Neurol Disord 2018; 11: 1756286 418793562
- 5 Shams S, Arain A. Brown Sequard Syndrome. StatPearls; 2022. Accessed August 3, 2022 at: https://www.ncbi.nlm.nih.gov/books/NBK538135/
- 6 Aycan A, Celik S, Kuyumcu F. et al. Spinal metastasis of unknown primary accompanied by neurologic deficit or vertebral instability. World Neurosurg 2018; 109: e33-e42
- 7 Chen W, Hika B, Smith CJ, Parrett TJ, Mesfin FB. A conservative approach to the treatment of a rare case of cervical spine double expressor diffuse large B-cell lymphoma: a case report. Cureus 2022; 14 (01) e21208
- 8 Iriyama C, Murate K, Iba S. et al. Detection of circulating tumor DNA in cerebrospinal fluid prior to diagnosis of spinal cord lymphoma by flow cytometric and cytologic analyses. Ann Hematol 2022; 101 (05) 1157-1159
- 9 Erdem MB, Kale A, Yaman ME, Emmez H. A rare entity in the lumbar epidural region: T-cell lymphoblastic lymphoma. Int J Spine Surg 2021; 14 (s4): S52-S56
- 10 De Vries J, Oterdoom MD, Den Dunnen WF. et al. Primary cauda equina T-cell lymphoblastic lymphoma. World Neurosurg 2020; 142: 227-232
- 11 Natteru PA, Shekhar S, Nair LR, Uschmann H. Primary central nervous system lymphoma mimicking longitudinally extensive transverse myelitis. Neurohospitalist 2021; 11 (02) 170-174
- 12 Wang D, Su M, Xiao J. A rare case of primary ventricular lymphoma presented on FDG PET/CT. Clin Nucl Med 2020; 45 (02) 156-158
- 13 Singh SS, Mittal BR, Kumar R, Singh H, Balaini N, Goyal M. Primary central nervous system lymphoma with diffuse neurolymphomatosis involving multiple cranial and spinal nerve roots. Clin Nucl Med 2020; 45 (06) e285-e287
- 14 Fakhouri F, Shoumal N, Obeid B, Alkhoder A. Primary diffuse large B-cell non-Hodgkin's lymphoma of the thoracic spine presented initially as an epigastric pain. Asian J Neurosurg 2020; 15 (01) 162-164
- 15 Pandey S, Gokden M, Kazemi NJ, Post GR. Hematolymphoid malignancies presenting with spinal epidural mass and spinal cord compression: a case series with rare entities. Ann Clin Lab Sci 2019; 49 (06) 818-828
- 16 Beume LA, Wolf K, Urbach H. et al. Primary intraspinal non-Hodgkin's lymphoma: case report and review of literature. J Clin Neurosci 2019; 61: 262-264
- 17 Yim J, Song SG, Kim S. et al. Primary peripheral gamma delta T-cell lymphoma of the central nervous system: Report of a case involving the intramedullary spinal cord and presenting with myelopathy. J Pathol Transl Med 2019; 53 (01) 57-61
- 18 Feng L, Chen D, Zhou H. et al. Spinal primary central nervous system lymphoma: case report and literature review. J Clin Neurosci 2018; 50: 16-19
- 19 Arslan H, Yavuz A, Aycan A. Primary spinal lymphoma masquerading as meningioma: preoperative and postoperative magnetic resonance imaging findings. World Neurosurg 2018; 118: 86-87
- 20 Li X, Qi S, Jiao Y, Gao J, Du H. A case report of primary central nervous system lymphoma with intestinal obstruction as the initial symptom. Medicine (Baltimore) 2018; 97 (10) e0080
- 21 Suzuki K, Yasuda T, Hiraiwa T, Kanamori M, Kimura T, Kawaguchi Y. Primary cauda equina lymphoma diagnosed by nerve biopsy: a case report and literature review. Oncol Lett 2018; 16 (01) 623-631
- 22 Patel M, Wu OC, Kasliwal MK. Wrap-around appearance: underrecognized radiologic feature of spinal lymphoma. World Neurosurg 2018; 115: 157-158
- 23 Fastré S, London F, Lelotte J, Camboni A, Jeanjean A. Primary central nervous system lymphoma of T-cell origin: an unusual cause of spinal cord disease. Acta Neurol Belg 2017; 117 (03) 765-767
- 24 Geevarghese R, Marcus R, Aizpurua M, Al-Sarraj S, Ashkan K. Non-Hodgkin lymphoma of the cauda equina: a rare entity. Br J Neurosurg 2017; 31 (06) 734-735
- 25 Alaya Z, Achour B. Primary spinal marginal zone lymphoma: an unusual cause of spinal cord compression. Pan Afr Med J 2017; 27: 171
- 26 Chida K, Sugawara A, Koji T. et al. Primary intramedullary malignant lymphoma in the cervical cord with a presyrinx state. Cureus 2017; 9 (12) e2006
- 27 Córdoba-Mosqueda ME, Guerra-Mora JR, Sánchez-Silva MC, Vicuña-González RM, Torre AI. Primary spinal epidural lymphoma as a cause of spontaneous spinal anterior syndrome: a case report and literature review. J Neurol Surg Rep 2017; 78 (01) e1-e4
- 28 Samartzis D, Gillis CC, Shih P, O'Toole JE, Fessler RG. Intramedullary spinal cord tumors: part i-epidemiology, pathophysiology, and diagnosis. Global Spine J 2015; 5 (05) 425-435
- 29 Ogden AT, Francavilla TL. Intramedullary Spinal Cord Tumors. Medscape; 2020. Accessed August 3, 2022 at: https://emedicine.medscape.com/article/251133
- 30 Tuz Zahra F, Ajmal Z, Qian J, Wrzesinski S. Primary intramedullary spinal melanoma: a rare disease of the spinal cord. Cureus 2021; 13 (07) e1619
- 31 Raffa PEAZ, Vencio RCC, Ponce ACC. et al. Spinal intramedullary abscess due to Candida albicans in an immunocompetent patient: a rare case report. Surg Neurol Int 2021; 12: 275
- 32 Bowzyk Al-Naeeb A, Ajithkumar T, Behan S, Hodson DJ. Non-Hodgkin lymphoma. BMJ 2018; 362: k3204
- 33 Urasaki E, Yamada H, Tokimura T, Yokota A. T-cell type primary spinal intramedullary lymphoma associated with human T-cell lymphotropic virus type I after a renal transplant: case report. Neurosurgery 1996; 38 (05) 1036-1039
- 34 Mullangi S, Lekkala MR. CNS Lymphoma. StatPearls; 2021. Accessed August 3, 2022 at: https://www.ncbi.nlm.nih.gov/books/NBK563302/
- 35 Dähnert W. Radiology Review Manual. Nucl Med Commun 2011; 32 (10) 195-196
- 36 Flanagan EP, O'Neill BP, Porter AB, Lanzino G, Haberman TM, Keegan BM. Primary intramedullary spinal cord lymphoma. Neurology 2011; 77 (08) 784-791
- 37 Hochberg FH, Miller DC. Primary central nervous system lymphoma. J Neurosurg 1988; 68 (06) 835-853
- 38 Kitley JL, Leite MI, George JS, Palace JA. The differential diagnosis of longitudinally extensive transverse myelitis. Mult Scler 2012; 18 (03) 271-285
- 39 Cobo-Calvo Á, Alentorn A, Mañé Martínez MA. et al. Etiologic spectrum and prognosis of longitudinally extensive transverse myelopathies. Eur Neurol 2014; 72 (1-2): 86-94
- 40 Elavarasi A, Dash D, Warrier AR. et al. Spinal cord involvement in primary CNS lymphoma. J Clin Neurosci 2018; 47: 145-148
- 41 Fitzsimmons A, Upchurch K, Batchelor T. Clinical features and diagnosis of primary central nervous system lymphoma. Hematol Oncol Clin North Am 2005; 19 (04) 689-703 , vii
- 42 Haque S, Law M, Abrey LE, Young RJ. Imaging of lymphoma of the central nervous system, spine, and orbit. Radiol Clin North Am 2008; 46 (02) 339-361 , ix
- 43 Bekar A, Cordan T, Evrensel T, Tolunay S. A case of primary spinal intramedullary lymphoma. Surg Neurol 2001; 55 (05) 261-264
- 44 Schwarz S, Zoubaa S, Knauth M, Sommer C, Storch-Hagenlocher B. Intravascular lymphomatosis presenting with a conus medullaris syndrome mimicking disseminated encephalomyelitis. Neuro-oncol 2002; 4 (03) 187-191
- 45 Iqbal S, Wein S. Lymphoma of the spinal cord. Radiopaedia.Org.; 2012. Accessed March 17, 2023 at: https://doi.org/10.53347/rid-19279